CAP1811 for self-amplifying RNA (saRNA)
Featured Product –
CAP m7G(5′)vppp(5′)(2’OMeA)pU
100mM Ammonium Solution
| Category | mRNAs: Cap Analog |
| Product Name | CAP m7G(5′)vppp(5′)(2’OMeA)pU 100mM Ammonium Solution |
If you request a sample or need a product consultation, please click it.
Product Description
CAP1811 is specifically designed for self-amplifying RNAs based on the genomes of positive sense strand RNA viruses such as
Venezuelan equine encephalitis virus (VEEV), Semliki forest virus (SFV), and Sindbis virus (SIN).
Areterna’s novel CAP1811 is different from commercial cap analogs of AU. CAP1811 is not limited by patents and comparable to AU in
saRNA transcription yield, integrity, capping rate. In addition, the resulting protein expression from the saRNA is high.
High performance & Cost effective. GMP-grade available
Independent intellectual property rights with no patent restrictions
High saRNA protein expression
Ordering Information
| Cat. No. | Size |
| CAP1811-0.1 | 100 μL |
| CAP1811-1 | 1 mL |
| CAP1811-10 | 10 mL |
| CAP1811-100 |
100 mL |
| CAP1811-500 |
500 mL |
Recommended IVT Condition
| Component | Volume |
| 10×Transcription Buffer | 2 μl |
| CAP1811(100mM) | 2 μl |
| ATP/CTP/GTP/UTP(100mM each) | 2 μl each |
| T7 RNA Polymerase(250 U/μL) | 1 μl |
| Inorganic Pyrophosphatase(1 U/μL) | 0.04 μl |
| Murine RNase inhibitor (40 U/μL) | 1 μl |
| DNA Template | 1 μg |
| RNase free H2O | Up to 20 μl |